Feed Top Reports Pricing

⌘K

13:52:02·1221d

NEWSReleasevia Quantisnow

Class Acceleration Shares Resume Trading

ByQuantisnow·Wall Street's wire, on your screen.

CLAS· Class Acceleration Corp.

Industrials

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLAS (Class Acceleration Corp.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

CLAS
Class Acceleration Corp.
Industrials

Related

13D/G1165d
SEC Form SC 13G/A filed by Class Acceleration Corp. (Amendment)
13D/G1165d
SEC Form SC 13G/A filed by Class Acceleration Corp. (Amendment)
SEC1198d
SEC Form 15-12G filed by Class Acceleration Corp.
SEC1211d
SEC Form 25-NSE filed by Class Acceleration Corp.
SEC1213d
Class Acceleration Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
NEWS1221d
Class Acceleration Corp. Amends Charter And Announces Decision To Liquidate
PR1221d
Class Acceleration Corp. Amends Charter and Announces Decision to Liquidate
PR1226d
Class Acceleration Corp. Files Proxy to Extend the Date to Consummate a Business Combination

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022